Gross Margin
21.58%vs Specialty Chemicals peers Updated Aug 19, 2026Profit Margin
8.75%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Margin
11.82%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Assets (TTM)
4.92%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Equity (TTM)
12.45%vs Specialty Chemicals peers Updated Aug 19, 2026Revenue (TTM)
5.69BCNY843.99M · vs all stocks (USD) Updated Aug 19, 2026Revenue per Share (TTM)
5.03CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-9.90%vs Specialty Chemicals peers Updated Aug 19, 2026Gross Profit (TTM)
1.12BCNY166.37M · vs all stocks (USD) Updated Aug 19, 2026EBITDA (TTM)
687.99MCNY102.03M · vs all stocks (USD) Updated Aug 19, 2026Net Income (TTM)
497.81MCNY73.83M · vs all stocks (USD) Updated Aug 19, 2026Quarterly Earnings Growth (YoY)
-11.80%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Cash Flow (TTM)
762.91MCNY113.14M · vs all stocks (USD) Updated Aug 19, 2026Levered Free Cash Flow (TTM)
685.99MCNY101.73M · vs all stocks (USD) Updated Aug 19, 2026Trailing Annual Dividend Rate
0.2000CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
3.84%Updated Aug 19, 20265-Year Average Dividend Yield
2.84%Updated Aug 19, 2026Payout Ratio
40.91%vs Specialty Chemicals peers Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 45.45%.Updated Aug 19, 2026Minority Interest (Equity)
13.12MCNYFY2025 · Dec 31, 2025Revenue
5.83BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
4.71BCNYFY2025 · Dec 31, 2025Gross Profit
1.13BCNYFY2025 · Dec 31, 2025Operating Income
644.86MCNY95.63M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
590.07MCNYFY2025 · Dec 31, 2025Income Tax Expense
73.01MCNYFY2025 · Dec 31, 2025Net Income
517.06MCNYFY2025 · Dec 31, 2025EBIT
645.94MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
1.07BCNYFY2025 · Dec 31, 2025Research & Development
209.10MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
84.06MCNYFY2025 · Dec 31, 2025Other Operating Expenses
40.48MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
28.32MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
55.88MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.4500CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.4500CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.14BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.14BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
517.06MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-2.71MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
426.72MCNYFY2025 · Dec 31, 2025Free Cash Flow
212.79MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
727.49MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
517.06MCNYFY2025 · Dec 31, 2025Other Non-cash Items
-13.87MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-164.36MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
87.88MCNYFY2025 · Dec 31, 2025Capital Expenditures
-213.93MCNYFY2025 · Dec 31, 2025Purchase of Investments
-4.10BCNYFY2025 · Dec 31, 2025Sale of Investments
3.84BCNYFY2025 · Dec 31, 2025Other Investing Activity
-338.64MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-816.99MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
3.30BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-3.02BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-256.50MCNYFY2025 · Dec 31, 2025Other Financing Charges
99.18MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
118.10MCNYFY2025 · Dec 31, 2025